During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

SELLAS Life Sciences Group (NASDAQ:SLS) announced on Thursday promising mid-stage trial results for SLS009, a highly ...

Sellas Life Sciences (SLS) announced data from Phase 2a trial of SLS009 – tambiciclib -, a highly selective CDK9 inhibitor, in ...

China's National Medical Products Administration has approved a Phase III trial of InnoCare Pharma’s ICP-248 (Mesutoclax) ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

A third of people believe asexuality can be “cured” by therapy, a new study that examines misconceptions of the sexual orientation suggests. Asexual people experience little or no sexual ...

You’ll find dermatologists who have experience with cutaneous T-cell lymphoma at Find a Dermatologist ... Due to possible side effects, this medication is prescribed to treat small areas of skin.

The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...

Even for a band that had been going strong and been as consistent as The Cure, Robert Smith knew that some records set the bar a little higher than others. Looking back at where the goth legends ...

The National Health Service (NHS) has approved a groundbreaking £1.65 million treatment for sickle cell disease in England, offering patients a promising 96.6% cure rate. The new therapy, hailed as a ...